Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes-Reference-Cited by-同舟云学术

Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes

Published:2016-10 Issue:4 Volume:196 Page:1082-1089
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Ory Jesse¹²,Flannigan Ryan¹,Lundeen Colin¹,Huang James G.¹³,Pommerville Peter¹,Goldenberg S. Larry¹

Affiliation:

1. Department of Urological Sciences, University of British Columbia, Vancouver, British Columbia

2. Department of Urology, Dalhousie University, Halifax, Nova Scotia, Canada

3. Western Hospital, University of Melbourne and Monash Medical Centre, Monash University, Melbourne, Victoria, Australia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. Prevalence of symptomatic androgen deficiency in men;Araujo;J Clin Endocrinol Metab,2007

2. Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review;Hellstrom;Int Urol Nephrol,2012

3. The effect of castration, of estrogen and of androgen injection on serum phosphatase on metastatic carcinoma of the prostate;Huggins;Cancer Res,1941

4. Risks of testosterone-replacement therapy and recommendations for monitoring;Rhoden;N Engl J Med,2004

5. Testosterone and prostate cancer: an historical perspective on a modern myth;Morgentaler;Eur Urol,2006

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Risk and Monitoring During Testosterone Replacement Therapy;The Journal of Clinical Endocrinology & Metabolism;2024-05-16

2. The testosterone replacement therapy for prostate cancer patients: Time to take the leap?;Andrology;2024-05-09

3. Oncologic Outcomes of Testosterone Therapy for Men on Active Surveillance for Prostate Cancer: A Population-based Analysis;European Urology Open Science;2024-02

4. Does testosterone replacement therapy increase the risk of conversion to treatment in patients with prostate cancer on active surveillance?;Urologic Oncology: Seminars and Original Investigations;2023-10

5. Testosterone Treatment of Men with Unequivocal Hypogonadism Following Treatment of Organ-Confined Prostate Cancer;Endocrine Practice;2023-09